Compton Capital Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-25,000
| Closed | -$10K | – | 152 |
|
|
2016
Q3 | $10K | Buy |
25,000
+15,000
| +150% | +$6K | ﹤0.01% | 146 |
|
|
2016
Q2 | $5K | Sell |
10,000
-10,000
| -50% | -$5K | ﹤0.01% | 143 |
|
|
2016
Q1 | $27K | Buy |
20,000
+5,000
| +33% | +$6.75K | 0.02% | 141 |
|
|
2015
Q4 | $22K | Hold |
15,000
| – | – | 0.01% | 138 |
|
|
2015
Q3 | $24K | Hold |
15,000
| – | – | 0.01% | 131 |
|
|
2015
Q2 | $26K | Hold |
15,000
| – | – | 0.01% | 140 |
|
|
2015
Q1 | $21K | Hold |
15,000
| – | – | 0.01% | 138 |
|
|
2014
Q4 | $23K | Hold |
15,000
| – | – | 0.01% | 143 |
|
|
2014
Q3 | $31K | Hold |
15,000
| – | – | 0.02% | 137 |
|
|
2014
Q2 | $46K | Buy |
+15,000
| New | +$46K | 0.02% | 138 |
|
|
2014
Q1 | – | Sell |
-12,000
| Closed | -$60K | – | 146 |
|
|
2013
Q4 | $60K | Hold |
12,000
| – | – | 0.03% | 137 |
|
|
2013
Q3 | $27K | Hold |
12,000
| – | – | 0.02% | 139 |
|
|
2013
Q2 | $27K | Buy |
+12,000
| New | +$27K | 0.02% | 144 |
|